OLANZAPINE TEVA ® 7.5 MG

البلد: إسرائيل

اللغة: الإنجليزية

المصدر: Ministry of Health

العنصر النشط:

OLANZAPINE 7.5 MG

متاح من:

SALOMON,LEVIN & ELSTEIN LTD

ATC رمز:

N05AH03

الشكل الصيدلاني:

FILM COATED TABLETS

طريقة التعاطي:

PER OS

المصنعة من قبل:

TEVA OPERATIONS POLAND SP.ZO.O

المجموعة العلاجية:

OLANZAPINE

الخصائص العلاجية:

Acute and maintenance treatment of schizophrenia. Olanzapine Teva® is indicated for the management of the manifestations of psychotic disorders. Olanzapine Teva® is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.Prevention of recurrence in Bipolar Disorder: In patients whose manic episode has responded to olanzapine treatment Olanzapine Teva® is indicated for the prevention of recurrence in patients with Bipolar Disorder. Combination therapy in Bipolar I Disorder. The combination of Olanzapine Teva® with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.

تاريخ الترخيص:

2011-04-01